Skip Navigation


European Heart Journal Advance Access originally published online on November 6, 2008
European Heart Journal 2008 29(23):2829-2830; doi:10.1093/eurheartj/ehn519
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
29/23/2829    most recent
ehn519v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lassen, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lassen, J. F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

Two stent or not two stent—that is the question

Jens Flensted Lassen*

Department of Cardiology B, Aarhus University Hospital, Skejby, Denmark

* Corresponding author: Tel: +45 89496248. Fax: +45 89496002. Email: jens.lassen@ki.au.dk

This editorial refers to ‘Randomized trial on routine vs. provisional stenting in the treatment of de novo coronary bifurcation lesions’{dagger} by M. Ferenc et al., on page 2859

Footnotes

The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.

The first 10% of the full text of this article appears below.

Coronary bifurcations account for up to 15% of all percutaneous coronary interventions (PCIs) and are one of the most challenging lesions in interventional cardiology.1 The treatment strategy has rapidly improved over the years. Initially, bifurcation lesion treatment used to be associated with a high risk of complications and restenosis.2,3 The use of drug-eluting stents (DES) and introduction of different bifurcation stenting strategies and techniques resulted in marked improvements.4–6 Thus, the ARTS II study had comparable event . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Randomized trial on routine vs. provisional T-stenting in the treatment of de novo coronary bifurcation lesions
Miroslaw Ferenc, Michael Gick, Rolf-Peter Kienzle, Hans-Peter Bestehorn, Klaus-Dieter Werner, Thomas Comberg, Piotr Kuebler, Heinz Joachim Büttner, and Franz-Josef Neumann
EHJ 2008 29: 2859-2867. [Abstract] [FREE Full Text]